Skip to main page content (V体育平台登录)
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in VSports app下载. gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely V体育官网. .

. 2008:2008:520465.
doi: 10.1155/2008/520465.

Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies

Mark A Deeg  1 , Meng H Tan
Affiliations

Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies

"VSports在线直播" Mark A Deeg et al. PPAR Res. 2008.

Abstract

Peroxisome proliferator-activated receptors (PPARs) play an important role in regulating both glucose and lipid metabolism. Agonists for both PPARgamma and PPARgamma have been used to treat dyslipidemia and hyperglycemia, respectively. In addition to affecting glucose metabolism, PPARgamma agonists also regulate lipid metabolism VSports手机版. In this review, we will focus on the randomized clinical trials that directly compared the lipid effects of the thiazolidinedione class of PPARgamma agonists, pioglitazone and rosiglitazone, head-to-head either as monotherapy or in combination with other lipid-altering or glucose-lowering agents. .

PubMed Disclaimer

Figures

Figure 1
Figure 1
See this image and copyright information in PMC

References

    1. Buse JB, Tan MH, Prince MJ, Erickson PP. The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes. Diabetes, Obesity and Metabolism. 2004;6(2):133–156. - PubMed
    1. Bell DS. Beneficial effects resulting from thiazolidinediones for treatment of type 2 diabetes mellitus. Postgraduate Medicine. 2003:35–44. - PubMed
    1. Yki-Järvinen H. Thiazolidinediones. The New England Journal of Medicine. 2004;351(11):1106–1118. - PubMed
    1. Ranganathan G, Unal R, Pokrovskaya I, et al. The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment. Journal of Lipid Research. 2006;47(11):2444–2450. - PMC - PubMed
    1. Tan GD, Olivecrona G, Vidal H, Frayn KN, Karpe F. Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: role of adipose tissue and skeletal muscle in response to rosiglitazone. Diabetologia. 2006;49(10):2412–2418. - "VSports app下载" PubMed

LinkOut - more resources